Thermo Fisher Scientific PDCL2 Polyclonal Antibody

Applications

Tested Dilution

Publications

Western Blot (WB)

0.04-0.4 µg/mL

-

Immunohistochemistry (Paraffin) (IHC (P))

1:1,000-1:2,500

-

Product Specifications

Species Reactivity

Human

Host/Isotype

Rabbit / IgG

Class

Polyclonal

Type

Antibody

Immunogen

Recombinant protein corresponding to Human PDCL2. Recombinant protein control fragment (Product #RP-100301). if (typeof window.$mangular === undefined || !window.$mangular) { window.$mangular = {}; } $mangular.antigenJson = \[{targetFamily:PDCL2,uniProtId:Q8N4E4-1,ncbiNodeId:9606,antigenRange:21-83,antigenLength:241,antigenImageFileName:PA5-61695_PDCL2_Q8N4E4-1_Rabbit.svg,antigenImageFileNamePDP:PA5-61695_PDCL2_Q8N4E4-1_Rabbit_PDP.jpeg,sortOrder:1}\]; $mangular.isB2BCMGT = false; $mangular.isEpitopesModalImageMultiSizeEnabled = true;

View immunogen .st0{fill:#FFFFFF;} .st1{fill:#1E8AE7;}

Conjugate

Unconjugated Unconjugated Unconjugated

Form

Liquid

Concentration

0.2 mg/mL

Purification

Antigen affinity chromatography

Storage buffer

PBS, pH 7.2, with 40% glycerol

Contains

0.02% sodium azide

Storage conditions

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Shipping conditions

Wet ice

RRID

AB_2645318

Product Specific Information

Immunogen sequence: PPKEESKDEI EEMVLRLQKE AMVKPFEKMT LAQLKEAEDE FDEEDMQAVE TYRKKRLQEW KAL

Highest antigen sequence identity to the following orthologs: Mouse - 87%, Rat - 87%.

Target Information

Phosducin-like proteins (PhLPs) are a conserved family of proteins with thioredoxin-like domains that were initially identified as modulators of G protein signaling. PDCL2 is highly homologous to PDCL and shares an N-terminal helix domain and a C-terminal thioredoxin-fold (Trx-fold) domain. PDCL2 has been shown to interact with the chaperonin CCT and is essential for cytoskeletal protein function and cell cycle progression.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.